Premature Ejaculation Treatment Guidelines

Introduction to Pharmacological Treatment

• The American Urological Association recommends daily SSRI therapy as the most effective pharmacological treatment for premature ejaculation, with paroxetine demonstrating the strongest ejaculation delay among all SSRIs 1, 2

First-Line Treatment Options

• Paroxetine is the most effective SSRI for premature ejaculation, providing an 8.8-fold increase in ejaculatory latency time, and should be the first-line choice when prescribing daily SSRI therapy 1, 2
• The recommended starting dose of paroxetine is 10-20 mg daily, which can be titrated up to 40 mg based on response 1, 2
• Daily dosing of paroxetine provides substantially greater ejaculatory delay compared to on-demand administration 1

Alternative Treatment Options

• Sertraline 50-200 mg daily is a highly effective second-line option with established guideline support 1, 3
• Fluoxetine 20-40 mg daily is an effective but less potent alternative to paroxetine or sertraline 1
• Citalopram 20-40 mg daily is an effective alternative 1

On-Demand Treatment Options

• Dapoxetine 30-60 mg taken 1-3 hours before intercourse is specifically approved for premature ejaculation in many countries and produces a 2.5-3.0-fold increase in intravaginal ejaculatory latency time (IELT) 4, 2
• Topical lidocaine/prilocaine spray increases IELT up to 6.3-fold over 3 months and is a viable option for patients concerned about systemic medication effects 4, 2

Critical Safety Considerations

• The American Urological Association recommends never prescribing SSRIs to men with bipolar depression due to the risk of triggering mania 1, 3, 5
• Combining SSRIs with other serotonergic drugs should be avoided due to the risk of serotonin syndrome 1, 3

Treatment Algorithm

• For frequent sexual activity, start with paroxetine 10-20 mg daily and titrate to 40 mg if needed after 2-4 weeks 1, 2
• For infrequent sexual activity, consider dapoxetine 30-60 mg on-demand or topical lidocaine/prilocaine spray 4, 2

Common Pitfalls to Avoid

• On-demand SSRI dosing should not be used as first-line treatment when daily dosing is feasible due to substantial efficacy differences 3
• Approximately 40% of patients refuse or discontinue SSRI treatment within 12 months, highlighting the need for patient education and addressing concerns about antidepressant use upfront 1, 3